SAN FRANCISCO, Jan. 08, 2024 iRhythm Technologies, Inc. , a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today announced.
SAN FRANCISCO, Jan. 08, 2024 (GLOBE NEWSWIRE) iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today announced preliminary fourth quarter operational highlights and a business update at the 42nd Annual J.P. Morgan Healthcare Conference. Recent Operational Highlights and Financial Outlook Grew fourth quarter 2023 patient registrations in excess of 22% compared to the fourth quarter 2
Global Ocular Adhesives and Sealants Market to Outshine at US$ 455 5 Million Revenue by 2032 | Astute Analytica | medgadget.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medgadget.com Daily Mail and Mail on Sunday newspapers.
CE mark reinforces the Zio monitor system as a leading innovation in ambulatory cardiac monitoring and highlights the company’s commitment to providing the highest quality product and services globally
iRhythm Technologies Receives European Union s CE Marking Under Medical Device Regulation (EU MDR) for its Zio® monitor and ZEUS System | 03 01 24 finanzen.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.ch Daily Mail and Mail on Sunday newspapers.